ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
131 hedge funds and large institutions have $829M invested in Intra-Cellular Therapies Inc. in 2018 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 41 increasing their positions, 47 reducing their positions, and 19 closing their positions.
Holders
131
Holders Change
–
Holders Change %
0%
% of All Funds
3.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
41
Reduced
47
Closed
19
Calls
$30.8M
Puts
$21M
Net Calls
+$9.82M
Net Calls Change
+$5.83M
Top Buyers
1 |
PC
1
PointState Capital
New York
|
$39.3M |
2 |
2
T. Rowe Price Associates
Baltimore,
Maryland
|
$24.1M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$24.3M |
4 |
DFO
4
Duquesne Family Office
New York
|
$6.25M |
5 |
5
Balyasny Asset Management
Chicago,
Illinois
|
$8.47M |